Predicting Outcomes of Primary Treatment
Posted on: 11/01/2009
Prostate Cancer's Hidden Biology (May-June 2011)
Two New On-Line Calculators And An Up-Date Of An Older Standard (November 2008)
Molecular Diagnostics SNPs and Gene Expression Markers of Clinical Relevance. (TMPRSS2-ERG; PCA3) (June 2008)
PSA "Bounce" Following Permanent Seed Brachytherapy - A Challenge To Identify And A Cause Of Anxiety For Patients. (January 2008)
Long-Term Prognostic Significance of Primary Gleason Pattern in Patients With Gleason Score 7 Prostate Cancer: Impact on Prostate Cancer Specific Survival, J Urol, Feb 2006. (November 2007)
Adverse Prognosis Associated With "Detectable" PSA Following Prostatectomy (February 2007)
Nadir PSA after Radiation Therapy and Androgen Deprivation for Metastatic Disease (February 2007)
Kattan Preoperative Nomogram Updated (June 2006)
PSADT Predicts Survival After Biochemical Relapse Following Primary Therapy (August 2005)
PSA doubling time predicts likelihood of distant failure (October 2002)
Early Detection and Treatment Outcome for Aggressive Disease (March 2005) ( Including Age-Range PSA “normals” and PSA Velocity)
In This Section
